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SUMMARY 
Background: Conflicting reports about the toxicity of Synedrella nodiflora (L) Gaertn (family Asteraceae), a plant 
traditionally used in Ghana for the management of epilepsy, abound in literature. The present study evaluates the 
effect of a 90-day continuous oral administration of a hydro-ethanolic whole plant extract of Synedrella nodiflora 
(SNE) in male Sprague-Dawley rats.  
Methods: The toxicological evaluation of the extract (100, 300 and 1000 mgkg-1) was focused on haematological, 
serum biochemical parameters and histopathological changes of some isolated organs.  
Results: The extract produced no mortality in the rats treated during the study period. Only SNE 100 mgkg-1 pro-
duced significant decrease in white blood cell and neutrophil counts and an increase in albumin, globulin, total bili-
rubin, total protein and potassium levels. The higher doses (SNE 300 and 1000 mgkg-1) had no significant effect on 
all the haematological and biochemical parameters measured. Histopathological assessment of the liver, kidney and 
heart revealed no abnormalities in rats treated with the extracts. Only the SNE 1000 mgkg-1 produced distortions of 
the branching arrangements of the myocardial fibres and a congested vessel which indicates a healed infarction.  
Conclusions: The findings suggest hydro-ethanolic extract of Synedrella nodiflora (L) Gaertn generally has a low 
toxicity profile following a 90-day continuous oral administration in male Sprague-Dawley rats under the present 
laboratory conditions. However patients with renal or cardiac problems should use the plant with caution.  
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INTRODUCTION
Synedrella nodiflora (L.) Gaertn (family Asteraceae), 
commonly known as the node weed, is a herb found 
growing indiscriminately along the banks of rivers, 
streams and roadsides.1 In Ghana, the whole plant is 
boiled and the aqueous extract drunk for the treatment 
of epilepsy whiles the leaves are used for threatened 
abortion, hiccup, laxative and feed for livestock.1, 2 It is 
known that some indigenous tribes in Nigeria use the 
whole plant for the treatment of cardiac troubles and to 
stop wound bleeding.3 In Indonesia the young foliage is 
eaten as a vegetable and the leaf sap together with other 
materials, is applied for stomachache, and the plant is 
used in embrocation for rheumatism.4 In Malaysia, the 
leaves are as poultice on leg sores and for the treatment 
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The hydro-ethanolic extract of the whole plant has been 
found to possess anticonvulsant,5 sedative,6 in vitro an-
tioxidant and free radical scavenging7-9 and anti-
nociceptive properties.10 
 
Extracts of the aerial parts of S. nodiflora have been 
found to possess insecticidal property substantiating the 
use of the leaves of the plant by farmers in Ghana as 
post-harvest protectants to control storage pests.11-13 
However, reports from these studies suggest that the 
plant extract presented no neurotoxicity or neurobehav-
ioural effects in rats. 11 The young foliage of the plant is 
readily eaten by livestock in Ghana, Cameroon and oth-
er African countries whereas in Indonesia, it is eaten as 
a salad4,14 with no reported cases of toxicities in both 
humans and livestock. A number of studies have been 
conducted to evaluate the nutritive potential of 
Synedrella nodiflora in livestock and in one of these 
studies it was realized that supplementation of the feed 
of guinea pigs with the node weed plant protects the 
animals from copper and lead-induced toxicities.15 
However, a 14-day administration of an aqueous extract 
from the plant to male rats was found to have some de-
gree of toxicity on the haematological parameters, liver 
and also caused degenerative changes in the germinal 
epithelial cells of the seminiferous tubules. 16 Contrary 
to this report, a current toxicological assessment of a 
hydro-ethanolic extract from the plant suggests that it 
possess no observable toxicity in male Sprague-Dawley 
rats following a 14-day oral administration and the le-
thal dose of this extract was found to be greater than 
6400 mgkg-1.17,18 The present study was conducted with 
the aim of establishing the toxicological effects of a 
hydro-ethanolic extract following a 90-day continuous 
oral administration in male Sprague-Dawley rats and 
this will provide further information regarding the safe-




Plant collection and extraction 
Samples of the whole plant were collected from the Bo-
tanical Gardens, University of Ghana, Accra, in August 
2012 and authenticated by the Department of Botany, 
University of Ghana, Legon, Accra where a voucher 
specimen (PA01/UGSOP/GH12) was kept. The hydro-
ethanolic extract was made as previously described.5 
Briefly, the samples of the collected plant were air-dried 
for seven days and powdered. Suitable amounts of the 
powder were cold-macerated with 70 % v/v of ethanol 
in water. The hydro-ethanolic extract was then evapo-
rated to a syrupy mass under reduced pressure, air-dried 
and kept in a dessicator and the percent yield calculated. 
The resultant product was subsequently referred to as 
the extract or SNE. 
Phytochemical screening of SNE 
The hydro-ethanolic extract was tested qualitatively for 
the presence of flavonoids tannins, saponins, sterols, 
alkaloids, cardiac glycosides, coumarins, triterpernoids, 
anthraquinones and phenolic compounds based on test 
methods as previously described.19 
 
Animals 
A total of 20 Male Sprague-Dawley rats (Hsd:SD 
strain), weighing 150-200 g and 6-8 weeks old, were 
obtained from and maintained at the Department of An-
imal Experimentation, Noguchi Memorial Institute for 
Medical Research (NMIMR), University of Ghana, 
Legon, where all experimental procedures were per-
formed. All animal procedures and techniques used in 
these studies were approved by the Scientific and Tech-
nical Committee (STC) of the Noguchi Memorial Insti-
tute for Medical Research [reference number STC-6 (1) 
2012-13] and also by the Noguchi Institutional Animal 
Care and Use Committee (NIACUC), College of Health 
Sciences, University of Ghana with protocol number 
NIACUC-2012-01-1E. It was also ensured that all ex-
periments carried out on animals conformed to the 
OECD guidelines. The animals were housed in groups 
of five in stainless steel cages (34 cm x 47 cm x 18 cm) 
with soft wood shavings as bedding, fed with normal 
commercial pellet diet (AGRIMAT, Kumasi), were giv-
en water ad libitum and maintained under laboratory 
conditions (temperature 22±2 °C, relative humidity 60-
70%, and 12 hour light-dark cycle).  
 
Animal Groupings and extract administration  
The acclimatized SD rats were randomly grouped into 
four (five rats/group) namely; vehicle (distilled water 
1.667 mlkg-1), SNE 100 mgkg-1, SNE 300 mgkg-1 and 
SNE 1000 mgkg-1. The animals were dosed daily for 
ninety (90) days with vehicle and SNE by oral gavage in 
order to mimic the traditional folkloric route of admin-
istration. The doses of the extract were selected based 
on previously reported doses of the extract that were 
found to be pharmacologically active. 5,6,10 All drug ad-
ministrations were given at 8:00 GMT each day and the 
determinations ( e.g blood collection and post-mortem 
examinations) were done before 15:00 GMT. 
 
Clinical Observation and sub-chronic toxicity study 
Animals in each group were weighed on the first day 
before the extract administration and on the 14th, 42nd 
and 91st day of the experimental period. The animals 
were monitored daily after the extract/vehicle admin-
istration and observed for any clinically observed toxi-
dromes such as changes in movement, salivation, my-
driasis, respiratory pattern, piloerection, frequency and 
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Mortality was also recorded and the cause investigated. 
On day 91 of the study period, blood samples were col-
lected from each animal via cardiac puncture into BD 
microtainer brand tube with EDTA (1 ml) and BD vacu-
tainer SST – II Advance (5 ml) for haematological and 
biochemical analysis, respectively. An automated hae-
matology analyzer (KX-2IN, Sysmex Corporation, Ja-
pan) was used for the haematological analysis and Se-
lectra Junior version 04 autoanalyzer (Vital Scientific 
Bv, Netherlands) for the biochemical assays indicative 
of renal function (urea, creatinine, potassium and sodi-
um), lipid profile (total cholesterol, triglycerides, high 
density lipoprotein (HDL), low density lipoprotein 
(LDL), very low density lipoprotein (VLDL) cholester-
ol) and liver function (total protein, albumin, globulin, 
direct, indirect and total bilirubin, alanine aminotrans-
ferase (ALT), aspartate aminotransferase (AST) and 
alkaline phosphatase (ALP) enzyme assays).  
 
The rats were euthanized in a chloroform chamber and 
immediately autopsied. All visible organs and tissues 
were macroscopically examined, harvested and stored in 
formalin. A gross necropsy was performed and post-
mortem examinations conducted. All carcasses were 
incinerated. 
 
Histological Examination of some isolated organs 
The isolated hearts, livers and kidneys were preserved 
in 10% neutral buffered formalin solution for 7 days and 
washed with water. Tissues were cut with a disposable 
microtome blade, into approximately 3 mm thick slices. 
Three slices each were obtained from each of the organs 
under investigation. Dehydration of the organs was done 
using ethanol and in xylene. Paraffin wax blocks of the 
tissues were prepared and tissue blocks were cast using 
a molten wax dispenser, plastic cassettes and mould 
boxes. The tissue blocks were sectioned at 4µm using a 
rotary microtome. They were then mounted onto micro-
scopic slides and then dried overnight. The slides were 
later observed under a light microscope after being 
stained with hematoxylin and eosin (H&E) dyes. The 
slides were identified with codes written on the frosted 
sides of the slides. 
 
Data Analysis 
GraphPad Prism Version 5.0 for Windows (GraphPad 
Software, San Diego, CA, USA) was used for all statis-
tical analyses. Data was expressed as mean±SEM 
(Standard Error of Mean). P < 0.05 was considered sta-
tistically significant when data of test groups were com-
pared with that of vehicle-control in a one-way ANOVA 
followed by Dunnett’s multiple comparison test or a 
two-way ANOVA followed by a Bonferroni’s posthoc 
test where applicable.  
 
RESULTS 
Phytochemical screening of SNE 
SNE as screened for the presence of various phytochem-
ical constituents produced evidence for the presence of 
the following: flavonoids, tannins, saponins, alkaloids, 
cardiac glycosides, coumarins, triterpenoids, sterols, 
anthraquinones and phenols. 
 
Clinical Observations 
The SNE-treated rats did not show any observable ab-
normality in the movement, salivation, mydriasis, res-
piratory pattern, piloerection, frequency and consistency 
of stool of rats in comparison to the vehicle-treated 
group as daily observed and throughout the entire study 
period. No mortality was also recorded during the study 
period. 
 
Changes in animal weight  
There was no significant (P=0.98) difference in the 
weights of all the animals when measured on the 0, 14th, 
42nd and 91st day of the study (Table 1). 
 
Table 1 The effects of SNE (100, 300 and 1000 mgkg-1) 
on the weights (g) of rats in a 90-day sub-chronic toxici-
ty study.  
Day Body weight (g) 
Vehicle SNE 100mgkg-1 SNE 300mgkg-1 SNE 
1000mgkg-1 
0 218.80 ± 5.43 185.20 ± 10.15 184.00 ± 7.98 183.60 ± 13.30 
14 254.60 ± 8.48 241.60 ± 8.23 241.20 ± 11.91 229.20 ± 7.68 
42 344.40 ± 0.37 333.20 ± 12.94 328.80 ± 22.52 321.00 ± 12.37 
91 368.00 ± 11.95 361.60 ± 13.95 358.80 ± 24.06 364.50 ± 16.38 
 
Post-mortem Observations 
The post-mortem examination of the SNE and vehicle-
treated rats revealed no visible abnormal effect in all 
major organs observed. 
 
Organ Weight Variations  
There were no significant (p=0.96) variations in the 
weights of the major organs isolated from vehicle-
treated and the SNE-treated groups of rats (Table 2).  
 
Haematological Parameters 
The haematological analysis revealed a significant 
(p<0.01) decrease in the white blood cell and neutrophil 
counts for the SNE 100 mgkg-1 treated group (Table 3). 
There was, however, no significant difference (p=0.10-
0.56) between the vehicle and extract treated group 
(100, 300 and 1000 mgkg-1) with respect to the other 
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Table 2 The effects of SNE (100, 300 and 1000 mgkg-1) 
on the weights of major organs (g) isolated from rats in 
a 90-day sub-chronic toxicity study.  







Heart 1.10 ± 0.16 1.42 ± 0.05 1.42 ± 0.22 1.23 ± 0.08 
Lungs 1.96 ± 0.14 2.36 ± 0.15 1.94 ± 0.15 1.95 ± 0.16 
Kidneys 2.22 ± 0.10 2.50 ± 0.09 2.14 ± 0.20 2.08 ± 0.05 
Liver 12.90± 0.22 13.90 ± 0.52 11.90 ± 1.29 12.28 ± 0.37 
Brain 1.58 ± 0.07 1.68 ± 0.05 1.66 ± 0.05 1.58 ± 0.05 
Spleen 0.74 ± 0.05 0.84 ± 0.05 0.70 ± 0.05 0.73 ± 0.05 
Intestines 23.32± 0.71 20.96 ± 1.76 21.60 ± 1.76 21.15 ± 0.55 
Stomach 2.54 ± 0.08 2.63 ± 0.14 2.36 ± 0.20 2.58 ± 0.16 
Testicles 15.08± 1.20 14.68 ± 1.14 14.22 ± 0.98 14.08 ± 1.50 
 
Biochemical Parameters 
The serum biochemical markers as measured were 
grouped as those indicating the kidney function, lipid 
profile and liver function assays as indicated above. 
There was no significant difference (P=0.14-0.54) be-
tween the vehicle-treated and SNE (100, 300, 1000 
mgkg-1)-treated rats regarding the serum concentrations 
of urea, creatinine, and sodium (kidney function) of the 
rat subjects (Table 4). However, there was a significant 
(P<0.01) increase in potassium concentration in the 
SNE 100 mgkg-1-treated group.  
 
 
There was a significant difference (P=0.03) between the 
treatment groups with regards to  HDL levels but this 
difference was not significant for any of the SNE-
treated group in comparison to the control (Table 4). 
The other parameters measured for the lipid profile were 
not significantly different (P=0.08-0.99) for the SNE-
treated animals in comparison to those treated with the 
vehicle (Table 4). Regarding the liver function profile of 
the rats used in this study, there were significant differ-
ence between the vehicle-treated and the SNE-treated 
rats for albumin (P=0.04), globulin (P=0.01), total bili-
rubin (P=0.03) and total protein (P=0.003), and these 
parameters were only significantly high in the SNE 100 
mg/kg in comparison with the vehicle-treated groups. 
The other liver function parameters measured were not 
significantly different (P=0.28-0.83) for the SNE-treated 




Table 3 Haematological analysis of SNE (100, 300 and 1000 mgkg-1) after a 90-day observation period 
Parameter Vehicle SNE 100mgkg-1 SNE 300mgkg-1 SNE 1000mgkg-
1 
P value 
WBC (103 µL-1) 6.50± 0.73 2.42 ± 0.52** 5.92 ± 1.02 6.50 ± 0.25 0.03 
RBC (106 µL-1) 7.34 ± 0.24 7.90 ± 0.15 7.80 ± 0.18 8.05 ± 0.20 0.10 
HGB (g dL-1) 13.50 ± 0.37 12.06 ± 2.27 14.04 ± 0.37 14.48 ± 0.08 0.56 
HCT (%) 42.56± 1.10 45.00 ± 1.34 44.26 ± 1.36 46.30 ±  0.56 0.21 
MCV (fl) 58.08± 0.58 57.90 ± 0.68 56.66 ± 0.5 57.53 ± 0.72 0.38 
MCH (pg) 18.42 ± 0.18 15.52 ± 2.88 18.00 ± 0.16 18.03 ± 0.48 0.53 
MCHC (gdL-1) 31.68 ± 0.16 26.62 ± 4.86 31.76 ± 0.29 31.28± 0.45 0.43 
PLT (103 µL-1)  792.4 ± 19.88 523.0 ± 188.50 729.0 ± 100.80 756.50±114.90 0.38 
LYM (%) 82.52 ± 1.48 68.34 ± 17.25 76.14 ± 5.05 80.28 ± 2.94 0.73 
NEUT (%) 14.04 ± 1.25 26.64 ± 15.73 19.14 ± 3.96 15.45 ± 2.00 0.73 
LYM# (103 µL-1) 5.36 ± 0.67 2.63 ± 0.49 4.64 ± 0.97 5.25 ± 0.40 0.13 
NEUT# (103 µL-
1) 
0.94 ± 0.09 0.42 ± 0.13* 1.00 ± 0.17 0.98± 0.11 0.02 
RDW_SD (fl) 30.00 ± 0.28 30.22 ± 0.66 29.88 ± 0.41 29.80 ± 0.39 0.93 
RDW_CV (%) 11.50 ± 0.23 11.86 ± 0.37 11.82 ± 0.18 12.15 ± 0.55 0.63 
PDW (fl) 7.88 ± 0.16 9.47 ± 1.42 7.82 ± 0.14 7.90 ± 0.27 0.16 
MPV (fl) 6.76 ± 0.09 7.23 ± 0.48 6.22 ±0.10 6.87 ±0.18 0.27 
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Table 4 Biochemical analysis of a single administration of SNE (100, 300 and 1000 mgkg-1) after a 90-day observa-
tion period in SD male rats 
Parameters Vehicle SNE 100mgkg-1 SNE 300mgkg-1 SNE 1000mgkg-1 P value 
Renal function test (mmolL-1) 
Urea 8.95 ± 0.39 9.85 ± 0.82 9.01 ± 0.25 8.72 ± 0.31 0.45 
Creatinine  57.62 ± 2.01 50.14 ± 5.75 66.08 ± 6.91 63.55 ± 1.90 0.14 
Potassium  5.406 ± 0.42 15.04  ± 2.51** 7.30 ± 0.86 7.66 ± 0.87 0.001 
Sodium  145.00 ± 1.05 147.80 ± 3.15 144.60 ± 0.68 144.50 ± 0.65 0.53 
Lipid Profile (mmolL-1) 
Total Cholesterol  2.56 ± 0.15 2.62 ± 0.18 2.44 ± 0.09 2.56 ± 0.11 0.79 
Triglycerides 0.78 ± 0.07 1.36 ± 0.50 0.72 ± 0.14 0.74 ± 0.16 0.20 
HDL 1.06 ± 0.03 0.97 ± 0.02 0.98 ± 0.03 1.07 ± 0.03 0.04 
LDL 1.15 ± 0.14 0.35 ± 0.43 1.12 ± 0.06 1.15 ± 0.12 0.08 
VLDL 0.35 ± 0.03 0.37 ± 0.20 0.33 ± 0.07 0.34 ± 0.07 0.99 
Liver function test 
Total Protein (gL-1) 68.18 ± 1.20 82.56 ± 4.16** 67.22 ± 1.46 70.63 ± 1.92 0.003 
Albumin (gL-1) 34.12 ± 0.89 37.90 ± 1.80* 33.50 ± 0.66 35.18 ± 0.46 0.04 
Globulin (gL-1) 34.06 ± 1.13 59.90 ± 10.74* 33.70 ± 1.18 35.48 ± 1.56 0.01 
D. Bilirubin (µmolL-1) 1.66 ± 0.08 3.60 ± 2.07 1.56 ± 0.13 1.48 ± 0.10 0.36 
Ind. Bilirubin (µmolL-1) 0.24 ± 0.06 1.13 ± 1.00 0.30 ± 0.22 0.20 ± 0.04 0.48 
T. Bilirubin (µmolL-1) 1.90 ± 0.11 4.63 ± 1.35* 1.86 ± 0.16 1.68 ± 0.10 0.03 
ALT (UL-1) 66.66 ± 4.84 54.30  ± 22.81 83.68 ± 12.37 74.45 ± 4.92 0.38 
AST (IUL-1) 6.83 ± 3.05 3.10 ± 1.90 12.15 ± 4.47 16.40 ± 4.10 0.20 
ALP (UL-1) 66.00  ± 24.92 53.70 ± 28.67 45.60 ± 40.42 54.30 ± 53.28 0.49 
 
 
Figure 1 Photomicrographs of kidneys isolated from rats after 90-day 
continuous administration of (A) Vehicle, (B) SNE 100 mgkg-1, (C) 
SNE 300 mgkg-1 and (D) SNE 1000 mgkg-1 showing normal renal 
tubule (T) and glomeruli (G) (H&E staining, 100×).  
 
 
Figure 2 Photomicrographs of livers isolated from rats after 90-day 
continuous administration of (A) Vehicle, (B) SNE 100 mgkg-1, (C) 
SNE 300 mgkg-1 and (D) SNE 1000 mgkg-1 (H&E staining, 100×). 
The arrow shows the hepatocyte which are evenly distributed. 
 
 
Figure 3 Photomicrographs of hearts isolated from rats after 90-day 
continuous administration of (A) Vehicle, (B) SNE 100 mgkg-1, (C) 
SNE 300 mgkg-1 showing normal myocardial fibres with characteristic 
central nuclei and branching arrangement as indicated by the arrows 
and (D) SNE 1000 mgkg-1 showing obvious distortion of the branch-
ing arrangements of the myocardial fibres (F) and a congested vessel 
(V) with little or no inflammatory cell infiltration indicating a healed 
infarction (H&E staining, 100×). 
 
Histological Examination of some isolated organs 
The histopathological examination of the kidneys and 
liver did not reveal any abnormalities (Figures 1 and 2). 
The renal tubules and glomeruli were normal. The heart 
isolated from rat treated with the vehicle control, SNE 
100 mgkg-1 and SNE 300 mgkg-1 showed normal myo-
cardial fibres with characteristic central nuclei and 
branching arrangement (Figure 3 A, B and C). Howev-
er, the isolated hearts from rats treated with SNE 1000 
mgkg-1 revealed distortion of the branching arrange-
ments of the myocardial fibres and a congested vessel 
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DISCUSSION 
The present study was conducted to assess the toxicity 
of a hydro-ethanolic extract of Synedrella nodiflora (L) 
Gaertn following a 90-day continuous administration of 
increasing doses in male Sprague-Dawley rats.  
 
This was done to provide further information regarding 
the toxicological effects of the hydro-ethanolic extract 
of the whole plant.  
 
In general, the extract was found to possess low toxicity 
on haematological and biochemical parameters and very 
little histopathological changes in the isolated organs 
from the rats treated with the extract.  
 
The extract, SNE, did not alter the weight of the animals 
during the 90-day continuous administration since there 
was no significant difference between the weights of the 
animals treated with the vehicle and that treated with 
SNE. This indicates that the extract may not possess any 
ability to cause an abnormality in carbohydrate or fat 
metabolisms. 20-22 
 
Haematological parameters were measured in this study 
to determine the effect of the extract on blood and blood 
forming tissues. Measurement of full blood count in-
cluding the RBC count, haemoglobin concentration, and 
haematocrit, can establish the presence of anaemia 
whiles the mean corpuscular volume (MCV) and the 
reticulocyte count parameters are useful in classifying 
the anaemia.23-25  
 
The leucocytes, or white blood cells, including granulo-
cytes, may be subdivided into neutrophils, eosinophils, 
and basophils; monocytes; and lymphocytes. Granulo-
cytes and monocytes are nucleated amoeboid cells that 
are phagocytic and play a central role in the inflamma-
tory response and host defence.23 Decreased amounts of 
leucocytes denote leucopenia 24,26 and raised amounts 
suggest bacterial infections or blood disorders.27 Only 
SNE 100 mgkg-1 caused a decrease in the white blood 
cell count as well as the neutrophil counts whiles the 
other parameters did not significantly differ from the 
vehicle-control group, thus this low dose can cause leu-
copenia and neutropenia (decreased levels of neutro-
phils).28 Neutropenia predisposes patients to many bac-
terial and fungal infections.29 Decreased neutrophil 
counts may be immune-mediated (where antigen-
antibody reactions lead to the destruction of peripheral 
neutrophils, granulocyte precursors, or both) or non-
immune-mediated which may indicate a genetic predis-
position that results in direct neutrophil damage leading 
to inhibition of granulopoiesis or neutrophil function.30-
32 Further investigations into the mechanism(s) by 
which this leucopenia or agranulocytopenia as caused 
by SNE 100 mgkg-1 during a continuous 90-day admin-
istration in SD rats is warranted. The other higher doses 
of SNE (300 and 1000 mgkg-1) did not significantly 
affect the entire haematological parameters measured in 
comparison to the vehicle-control group, thus devoid of 
either enhancing haematopoiesis or causing haematoxic-
ities.  
On the effect of the extract on the mammalian renal 
system, only the low dose, SNE 100 mgkg-1, produced a 
significant increase in the levels of serum potassium (in 
comparison to the vehicle-control group). This increase 
in potassium denotes hyperkalaemia which may develop 
in patients with underlying disorders affecting potassi-
um handling, such as chronic renal failure, and those 
taking a combination of drugs.33 Drug-induced hyper-
kalaemia may also result when there is a reduction in 
renal potassium excretion due to hypoaldosteronism or 
an increase in extracellular potassium shifts or an in-
crease in potassium supply.34 Severe hyperkalaemia can 
cause life-threatening cardiac dysrhythmias.35 Given 
that the vast majority of body potassium is intracellular, 
the extracellular potassium concentration is significantly 
dependent on both the total amount of potassium in the 
body and the distribution of this potassium between the 
extracellular and intracellular fluid compartments.36 
Furthermore, the extracellular value does not necessari-
ly reflect total-body potassium and thus most drug-
induced hyperkalaemia may not produce any obvious 
excitation in the myocardial cells. 36  
 
Thus it is possible to have patients presenting with hy-
perkalaemia and yet at the same time be depleted of 
total-body potassium. Since the higher doses of the ex-
tract (300 and 1000 mgkg-1) produced no significant 
effect on the renal function indices, it may suggest the 
high doses of the extract are devoid of any effect wheth-
er therapeutic or adverse on the renal functions of SD 
male rats. 37 Moreover, histological assessment of the 
kidney revealed no observable abnormalities, thus but-
tressing the assertion that SNE may be devoid of any 
potentially threatening renal damage or impairment.  
 
Regarding the effect of the extract on the lipid profile, 
the data obtained shows that the extract did not signifi-
cantly affect the lipid profile (total cholesterol, HDL, 
LDL and VLDL cholesterols) of the male SD rats. Sig-
nificant increase in the total cholesterol LDL and VLDL 
cholesterols by an administration of a substance are 
consistently associated with possible risk of atheroscle-
rosis and cardiovascular diseases.38,39 Thus a long-term 
administration of SNE may not have any potential ther-
apeutic or adverse effect on lipid metabolism of SD 
male rats. However, a chronic toxicity study with simi-
lar data and also in a non-rodent model animal would be 
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Regarding the biochemical parameters as measured to 
reflect the liver function of the SD rats, namely (total 
protein, albumin, globulin, direct bilirubin, indirect bili-
rubin, total bilirubin, ALT, AST and ALP), albumin, 
globulin total bilirubin and total protein were signifi-
cantly elevated by SNE 100 mgkg-1. Increased levels of 
albumin may result from dehydration or high protein 
diet.40 Elevation in globulin and total protein levels has 
been associated with chronic infections (parasites, some 
cases of viral and bacterial infection), liver disease (bili-
ary cirrhosis, obstructive jaundice), carcinoid syndrome, 
rheumatoid arthritis, ulcerative colitis, multiple myelo-
mas, leukemias, Waldenstrom's macroglobulinaemia, 
autoimmunity (systemic lupus), collagen diseases and 
kidney dysfunction (nephrosis).41 The present data 
makes it difficult to ascertain the exact cause of this 
high level of serum globulin in the SNE 100 mgkg-1 
treated rats.  However, since globulins are proteins that 
include gamma globulins (antibodies) and a variety of 
enzymes and carrier/transport proteins, specific profile 
of the globulins needs to be determined by protein elec-
trophoresis to ascertain the exact group of globulins 
where the abnormality lies.24 Elevation in bilirubin lev-
els may suggest a liver and/ bile duct damage as well as 
enhanced haemoglobin breakdown.42-44 Since a 14-day 
continuous administration of SNE 100 mgkg-1 did not 
produce such results in male SD rats,18 it can be sug-
gested that a long-term administration of this dose be-
yond 14 days may present hyperbiluribinaemia. In con-
trast, higher doses of the extract (300 and 1000 mgkg-1) 
may not present any liver or bile duct damage during 
short-or long-term administration. This assertion is fur-
ther supported by the histological assessment of the 
liver from the rats pre-treated with SNE (100, 300 and 
1000 mgkg-1) showing no abnormalities.  
 
Histopathological assessment of the liver and kidneys 
revealed no organ abnormalities for SNE 100, 300 and 
1000 mgkg-1. However, only SNE 1000 mgkg-1 showed 
some distortion of the branching arrangements of the 
myocardial fibres and a congested vessel which sug-
gests a healed infarction.45,46 Though at this point it is 
unclear how this infarction resulted, it will be prudent to 
advice the traditional healer who uses the plant to be 
cautious when using it in patients with cardiac disor-
ders. The lower doses of SNE (100 and 300 mgkg-1) did 
not produce any observable abnormality thus may not 
have any cardiotoxicity in rats. 
 
The foliage from the plant is being eaten by livestock 
and humans as well with no reported or documented 
toxicities.4,14 Thus it can be said that toxicities as dis-
covered in the male SD rats can also occur in humans 
and such studies in patients who use this plant is war-
ranted.  
Future research evaluating the effects of the hydro-
ethanolic extract in female SD rats, non-vertebrates and 
even in primates should be considered to provide a ho-
listic overview of the toxicology of the plant. 
 
In conclusion, the hydro-ethanolic extract of Synedrella 
nodiflora (L) Gaertn general has a low toxicity profile 
following a 90-day continuous oral administration in 
male Sprague-Dawley rats. However, a low dose of 
100mgkg-1 may cause leucopenia (and/neutropenia), 
hyperbilirubinaemia and hyperkalaemia, whereas a high 
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